This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bamichem Co., Ltd., Incheon National University Research & Business Foundation, Samjin Pharmaceutical Co., Ltd.. Active years: 2026.
Company Filing History:
1 out of 1 
1 out of 12 
1 out of 1 Years Active: 2026
Title: Eunsun Song: Innovator in Pharmaceutical Chemistry
Introduction
Eunsun Song is a prominent inventor based in Seongnam-si, South Korea. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development of novel compounds.
Latest Patents
Eunsun Song holds 1 patent for her invention titled "Adamantane derivatives as inhibitors of focal adhesion kinase." This patent presents novel adamantane derivatives that serve as inhibitors of focal adhesion kinase, along with their pharmaceutically acceptable salts, stereoisomers, hydrates, or solvates. Additionally, it includes a pharmaceutical composition comprising these compounds, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Eunsun Song has worked with notable organizations, including Samjin Pharmaceutical Co., Ltd. and Incheon National University Research & Business Foundation. Her experience in these institutions has allowed her to apply her expertise in pharmaceutical research and development effectively.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
Eunsun Song's innovative work in developing adamantane derivatives highlights her significant contributions to pharmaceutical chemistry. Her research continues to pave the way for advancements in medical treatments.